Rivaroxaban EP/IH is a highly effective anticoagulant medication that helps prevent blood clots, providing patients with improved cardiovascular health and reduced risk of thromboembolic events. Its remarkable efficacy and safety profile make it a trusted choice in managing various conditions, such as deep vein thrombosis and atrial fibrillation.
| Specification | Details |
|---|---|
| Medication Type | Anticoagulant |
| Active Ingredient | Rivaroxaban |
| Mechanism of Action | Direct factor Xa inhibitor |
| Dosage Form | Oral tablet |
| Strengths Available | 2.5 mg, 5 mg, 10 mg, 15 mg, and 20 mg |
| Half-life | 5-9 hours |
| Time to Peak Effect | 2-4 hours |
| Duration of Action | Approximately 24 hours |
| Indications | Prevention and treatment of thromboembolic events |
| Common Uses | Deep vein thrombosis, atrial fibrillation, |
| pulmonary embolism, stroke prevention in | |
| non-valvular atrial fibrillation, and more. | |
| Contraindications | Hypersensitivity to rivaroxaban, active bleeding, |
| severe liver disease, and pregnancy (unless | |
| specifically indicated by a healthcare professional) | |
| Adverse Effects | Bleeding, anemia, dizziness, nausea, |
| bruising, and other potential side effects | |
| Interactions | CYP3A4 and P-gp inhibitors/inducers, |
| other anticoagulants, NSAIDs, and certain | |
| herbal supplements | |
| Monitoring Parameters | Regular monitoring of liver function tests, |
| complete blood count, and signs of bleeding | |
| Storage | Store at room temperature (20°C to 25°C) |
| Protect from moisture and light |
Copyright © 2023. All rights reserved. Design By Techno Mantra
Copyright © 2024 – All rights reserved. Design By Technomantra India / Technomantra Global / Technomantra us / Technomantra Canada Technomantra local / Technomantra Australia